BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 16166579)

  • 21. Agreement and variability in the interpretation of early CT changes in stroke patients qualifying for intravenous rtPA therapy.
    Grotta JC; Chiu D; Lu M; Patel S; Levine SR; Tilley BC; Brott TG; Haley EC; Lyden PD; Kothari R; Frankel M; Lewandowski CA; Libman R; Kwiatkowski T; Broderick JP; Marler JR; Corrigan J; Huff S; Mitsias P; Talati S; Tanne D
    Stroke; 1999 Aug; 30(8):1528-33. PubMed ID: 10436095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Susceptibility-weighted imaging for cerebral microbleed detection in super-acute ischemic stroke patients treated with intravenous thrombolysis.
    Bai Q; Zhao Z; Sui H; Xie X; Chen J; Yang J; Zhang L
    Neurol Res; 2013 Jul; 35(6):586-93. PubMed ID: 23561793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of CT angiography in thrombolysis decision-making for patients with presumed seizure at stroke onset.
    Sylaja PN; Dzialowski I; Krol A; Roy J; Federico P; Demchuk AM;
    Stroke; 2006 Mar; 37(3):915-7. PubMed ID: 16456124
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcome and symptomatic bleeding complications of intravenous thrombolysis within 6 hours in MRI-selected stroke patients: comparison of a German multicenter study with the pooled data of ATLANTIS, ECASS, and NINDS tPA trials.
    Thomalla G; Schwark C; Sobesky J; Bluhmki E; Fiebach JB; Fiehler J; Zaro Weber O; Kucinski T; Juettler E; Ringleb PA; Zeumer H; Weiller C; Hacke W; Schellinger PD; Röther J;
    Stroke; 2006 Mar; 37(3):852-8. PubMed ID: 16439696
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypodensity of >1/3 middle cerebral artery territory versus Alberta Stroke Programme Early CT Score (ASPECTS): comparison of two methods of quantitative evaluation of early CT changes in hyperacute ischemic stroke in the community setting.
    Mak HK; Yau KK; Khong PL; Ching AS; Cheng PW; Au-Yeung PK; Pang PK; Wong KC; Chan BP;
    Stroke; 2003 May; 34(5):1194-6. PubMed ID: 12690213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors associated with early recanalization failure following intravenous rt-PA therapy for ischemic stroke.
    Koga M; Arihiro S; Miyashita F; Yamamoto H; Yamada N; Nagatsuka K; Minematsu K; Toyoda K
    Cerebrovasc Dis; 2013; 36(4):299-305. PubMed ID: 24135558
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of suitability of thrombolysis in middle cerebral artery infarction: a proof of concept study of a stereologically-based technique.
    Phan TG; Donnan GA; Koga M; Mitchell LA; Molan M; Fitt G; Chong W; Holt M; Reutens DC
    Cerebrovasc Dis; 2007; 24(4):321-7. PubMed ID: 17690543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Open trial of intravenous tissue plasminogen activator in acute carotid territory stroke. Correlations of outcome with clinical and radiological data.
    Trouillas P; Nighoghossian N; Getenet JC; Riche G; Neuschwander P; Froment JC; Turjman F; Jin JX; Malicier D; Fournier G; Gabry AL; Ledoux X; Derex L; Berthezène Y; Adeleine P; Xie J; Ffrench P; Dechavanne M
    Stroke; 1996 May; 27(5):882-90. PubMed ID: 8623108
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of intracranial carotid artery calcification on the development of thrombolysis-induced intracerebral hemorrhage.
    Lin TC; Chao TH; Shieh Y; Lee TH; Chang YJ; Lee JD; Peng TI; Chang KC; Liou CW; Chang TY; Hung KL; Chang CH
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e455-62. PubMed ID: 23800497
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Magnetic Resonance Imaging-DRAGON score: 3-month outcome prediction after intravenous thrombolysis for anterior circulation stroke.
    Turc G; Apoil M; Naggara O; Calvet D; Lamy C; Tataru AM; Méder JF; Mas JL; Baron JC; Oppenheim C; Touzé E
    Stroke; 2013 May; 44(5):1323-8. PubMed ID: 23482603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcome and severe hemorrhagic complications of intravenous thrombolysis with tissue plasminogen activator in very old (> or =80 years) stroke patients.
    Berrouschot J; Röther J; Glahn J; Kucinski T; Fiehler J; Thomalla G
    Stroke; 2005 Nov; 36(11):2421-5. PubMed ID: 16210554
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice: the Multicenter rt-PA Stroke Survey.
    Tanne D; Kasner SE; Demchuk AM; Koren-Morag N; Hanson S; Grond M; Levine SR
    Circulation; 2002 Apr; 105(14):1679-85. PubMed ID: 11940547
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of pretreatment noncontrast CT Alberta Stroke Program Early CT Score on clinical outcome after intra-arterial stroke therapy.
    Yoo AJ; Zaidat OO; Chaudhry ZA; Berkhemer OA; González RG; Goyal M; Demchuk AM; Menon BK; Mualem E; Ueda D; Buell H; Sit SP; Bose A;
    Stroke; 2014 Mar; 45(3):746-51. PubMed ID: 24503670
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The rtPA (alteplase) 0- to 6-hour acute stroke trial, part A (A0276g) : results of a double-blind, placebo-controlled, multicenter study. Thromblytic therapy in acute ischemic stroke study investigators.
    Clark WM; Albers GW; Madden KP; Hamilton S
    Stroke; 2000 Apr; 31(4):811-6. PubMed ID: 10753980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thrombolysis with intravenous rtPA in a series of 100 cases of acute carotid territory stroke: determination of etiological, topographic, and radiological outcome factors.
    Trouillas P; Nighoghossian N; Derex L; Adeleine P; Honnorat J; Neuschwander P; Riche G; Getenet JC; Li W; Froment JC; Turjman F; Malicier D; Fournier G; Gabry AL; Ledoux X; Berthezène Y; Ffrench P; Dechavanne M
    Stroke; 1998 Dec; 29(12):2529-40. PubMed ID: 9836764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of baseline CT scan appearance and time to recanalization on clinical outcomes in endovascular thrombectomy of acute ischemic strokes.
    Goyal M; Menon BK; Coutts SB; Hill MD; Demchuk AM;
    Stroke; 2011 Jan; 42(1):93-7. PubMed ID: 21088240
    [TBL] [Abstract][Full Text] [Related]  

  • 37. "Clinical-CT mismatch" and the response to systemic thrombolytic therapy in acute ischemic stroke.
    Kent DM; Hill MD; Ruthazer R; Coutts SB; Demchuk AM; Dzialowski I; Wunderlich O; von Kummer R
    Stroke; 2005 Aug; 36(8):1695-9. PubMed ID: 16002756
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score.
    Barber PA; Demchuk AM; Zhang J; Buchan AM
    Lancet; 2000 May; 355(9216):1670-4. PubMed ID: 10905241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravenous thrombolytic therapy for acute ischemic stroke: the experience of a community hospital.
    Hsu YC; Sung SF; Ong CT; Wu CS; Su YH
    Acta Neurol Taiwan; 2009 Mar; 18(1):14-20. PubMed ID: 19537569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between magnetic resonance angiography-diffusion-weighted imaging mismatch and clinical outcome in endovascular treatment for acute ischemic stroke: subgroup analysis of the Recovery by Endovascular Salvage for Cerebral Ultra-acute Embolism--Japan Registry.
    Deguchi I; Dembo T; Yoshimura S; Sakai N; Okada Y; Kitagawa K; Kimura K; Hyogo T; Yamagami H; Egashira Y; Tanahashi N
    J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1471-6. PubMed ID: 24685994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.